Preoperative Celecoxib and Acetaminophen Versus Acetaminophen Alone for Pain Control After Pediatric Adenotonsillectomy

Part of paid clinical trials in New York, New York.

Sponsor
NYU Langone Health
Study ID
NCT07870447
Phase
PHASE1/PHASE2
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Adenotonsillectomy
  • Postoperative Pain

Eligibility Criteria

Sex
ALL
Age
2 Years - 18 Years
Healthy Volunteers
Not accepted

Interventions

  • Celecoxib — DRUG
    Oral celecoxib 6 mg/kg per dose (max 100 mg), given the evening before surgery and the morning of surgery
  • Acetaminophen — DRUG
    Intra-operative acetaminophen (Tylenol)
  • Dexamethasone — DRUG
    Intra-operative dexamethasone (Decadron)

Study Details

This is an open-label randomized study of approximately 500 pediatric patients (2-18 years of age, weighing more than 10 kg) undergoing adenotonsillectomy. Participants are assigned to a preoperative multimodal analgesic regimen (oral celecoxib the evening before and the morning of surgery, plus intra-operative dexamethasone and acetaminophen) or to standard of care (no pre-operative medication; intra-operative dexamethasone and acetaminophen). The primary aim is to compare postoperative pain control, measured by rescue analgesic consumption, over the first 72 hours after surgery. Secondary aims assess safety (postoperative bleeding and adverse medication events) and feasibility (healthcare utilization and caregiver satisfaction).

Key Dates

First listed
Oct 13, 2026
Start date
Nov 1, 2026
Status verified
Oct 2026
Primary completion
Aug 30, 2028
Completion
Dec 30, 2029

Study Design

Enrollment
500 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Pre-operative Celecoxib
    Pediatric patients (2-18 years, \>10 kg) undergoing adenotonsillectomy who receive oral celecoxib (6 mg/kg, max 100 mg) the evening before surgery and the morning of surgery, plus intra-operative dexamethasone (Decadron) and acetaminophen (Tylenol). Post-operative regimen is the attending's standard of care.
  • Active Comparator: No pre-operative medication
    Pediatric patients (2-18 years, \>10 kg) undergoing adenotonsillectomy who receive no pre-operative medication; intra-operative dexamethasone (Decadron) and acetaminophen (Tylenol) only. Post-operative regimen is the attending's standard of care.

Primary Outcome Measure

Rescue Analgesic Use in PACU [ Time Frame: PACU Stay (PACU arrival to PACU discharge) - Approximately 3 Hours ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
NYU Langone HealthNew YorkNew York10016-

Find similar trials in New York, NY

Related Studies